Caricamento...
MET/HGF pathway activation as a paradigm of resistance to targeted therapies
Resistance to targeted therapeutics is a key issue limiting the long-term utility of these medications in the management of molecularly selected subsets of cancer patients, including patients with non-small cell lung cancer harboring oncogenic alterations affecting EGFR, ALK and other genes. Bypass...
Salvato in:
| Pubblicato in: | Ann Transl Med |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5253284/ https://ncbi.nlm.nih.gov/pubmed/28164089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.12.09 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|